Screening for Depression in Children and Adolescents: US Preventive Services Task Force Recommendation Statement
- PMID: 26908686
- DOI: 10.1542/peds.2015-4467
Screening for Depression in Children and Adolescents: US Preventive Services Task Force Recommendation Statement
Abstract
Description: This article describes the update of the 2009 US Preventive Services Task Force (USPSTF) recommendation on screening for major depressive disorder (MDD) in children and adolescents.
Methods: The USPSTF reviewed the evidence on the benefits and harms of screening, accuracy of primary care-feasible screening tests, and benefits and harms of treatment with psychotherapy, medications, and collaborative care models in patients aged 7 to 18 years.
Population: This recommendation applies to children and adolescents aged ≤18 years who do not have an MDD diagnosis.
Recommendation: The USPSTF recommends screening for MDD in adolescents aged 12 to 18 years. Screening should be implemented with adequate systems in place to ensure accurate diagnosis, effective treatment, and appropriate follow-up (B recommendation). The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for MDD in children aged ≤11 years (I statement).
Copyright © 2016 by the American Academy of Pediatrics.
Similar articles
-
Screening for Depression in Children and Adolescents: U.S. Preventive Services Task Force Recommendation Statement.Ann Intern Med. 2016 Mar 1;164(5):360-6. doi: 10.7326/M15-2957. Epub 2016 Feb 9. Ann Intern Med. 2016. PMID: 26858097
-
Screening for Depression in Adults: US Preventive Services Task Force Recommendation Statement.JAMA. 2016 Jan 26;315(4):380-7. doi: 10.1001/jama.2015.18392. JAMA. 2016. PMID: 26813211
-
Screening for primary hypertension in children and adolescents: U.S. Preventive Services Task Force recommendation statement.Pediatrics. 2013 Nov;132(5):907-14. doi: 10.1542/peds.2013-2864. Epub 2013 Oct 7. Pediatrics. 2013. PMID: 24101758 Review.
-
Screening for Depression and Suicide Risk in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.JAMA. 2022 Oct 18;328(15):1534-1542. doi: 10.1001/jama.2022.16946. JAMA. 2022. PMID: 36219440
-
Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement.JAMA. 2022 Aug 23;328(8):746-753. doi: 10.1001/jama.2022.13044. JAMA. 2022. PMID: 35997723 Review.
Cited by
-
Screening Adolescents for Sensitive Health Topics in Primary Care: A Scoping Review.J Adolesc Health. 2022 May;70(5):706-713. doi: 10.1016/j.jadohealth.2021.10.028. Epub 2021 Dec 23. J Adolesc Health. 2022. PMID: 34955356 Free PMC article.
-
Youth Depression Screening with Parent and Self-Reports: Assessing Current and Prospective Depression Risk.Child Psychiatry Hum Dev. 2019 Aug;50(4):647-660. doi: 10.1007/s10578-019-00869-6. Child Psychiatry Hum Dev. 2019. PMID: 30737605 Free PMC article.
-
Pediatrician and Behavioral Clinician-Delivered Screening, Brief Intervention and Referral to Treatment: Substance Use and Depression Outcomes.J Adolesc Health. 2018 Apr;62(4):390-396. doi: 10.1016/j.jadohealth.2017.10.016. Epub 2018 Feb 1. J Adolesc Health. 2018. PMID: 29396080 Free PMC article. Clinical Trial.
-
A cluster randomised controlled trial of a web-based youth mental health service in Australian schools.Lancet Reg Health West Pac. 2021 Jun 12;12:100178. doi: 10.1016/j.lanwpc.2021.100178. eCollection 2021 Jul. Lancet Reg Health West Pac. 2021. PMID: 34527971 Free PMC article.
-
Association between depressive symptoms and diagnosis of diabetes and its complications: A network analysis in electronic health records.Front Psychiatry. 2022 Sep 23;13:966758. doi: 10.3389/fpsyt.2022.966758. eCollection 2022. Front Psychiatry. 2022. PMID: 36213916 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
